Therapeutic use of the Arts for Patients with Multiple Sclerosis
People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social, and spiritual needs of patients facing a variety of chronic illnesses. Our review of the literature suggests that therapeutic art can be beneficial to individuals with MS, particularly in promoting self-efficacy, emotional well-being, and motor control. However, the body of evidence is limited, and further research is needed regarding the outcomes and mechanism of action of therapeutic arts in MS to better understand their role in the management of the consequences of the disease.
Music therapy, art therapy, dance therapy, multiple sclerosis
Lisa Gallagher and Francois Bethoux have nothing to disclose in relation to this article. No funding was received in the publication of this article.
Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.
Lisa M Gallagher, Cleveland Clinic Arts & Medicine Institute, 1950 Richmond Rd/TR308, Lyndhurst, OH 44124, US. E: firstname.lastname@example.org
This article is published under the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, adaptation, and reproduction provided the original author(s) and source are given appropriate credit.
Share this Article
Related Content In Multiple Sclerosis
Updates in Paediatric Acute Disseminated Encephalomyelitis and Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
touchREVIEWS in Neurology. 2023;19(1):Online ahead of journal publication
Acute disseminated encephalomyelitis (ADEM), first characterized in 1931,1 is a non-specific clinical syndrome of polyfocal central nervous system (CNS) inflammatory demyelination; it is characterized by encephalopathy and large, poorly demarcated cerebral white matter lesions.2,3 Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), a specific neuronal antibody-mediated disease that can often present as ADEM, was discovered only in the last decade.4 Both […]
Foreword – touchREVIEWS in Neurology, Volume 18, Issue 2, 2022
Welcome to our new issue of touchREVIEWS in Neurology, which features a wide range of topical articles covering various areas of neurology. We begin with two practice pearls. The first from Garg et al., focusses on the increasingly important subject of social media. Twitter provides a useful platform for clinicians, and this article provides advice on […]
Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis
touchREVIEWS in Neurology. 2022;18(2):117–21 DOI: https://doi.org/10.17925/USN.2022.18.2.117
Over the past two decades, monoclonal antibodies targeting the surface antigen CD20 have emerged as highly effective disease-modifying therapies (DMTs) for multiple sclerosis (MS).1 The major mechanism of action of these therapies is via B-cell depletion, as CD20 is expressed throughout much of the B-cell lineage, including pre-B-cells through memory B-cells. B-cells play multiple roles in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!